Caxton Associates (New York)’s Innospec IOSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,659
Closed -$240K 599
2021
Q4
$240K Hold
2,659
0.02% 463
2021
Q3
$224K Hold
2,659
0.02% 379
2021
Q2
$241K Buy
+2,659
New +$264K 0.03% 373
2020
Q4
Sell
-4,536
Closed -$287K 234
2020
Q3
$287K Buy
+4,536
New +$337K 0.03% 202

Other funds holding IOSP

Caxton Associates (New York)'s IOSP Position: Q1 2022 in Review

Caxton Associates (New York) sold out of Innospec (IOSP) in Q1 2022, closing a stake of 2,659 shares — an estimated $240K sold.

Caxton Associates (New York) first reported a position in IOSP in Q3 2020 and held it in 4 quarters. The position peaked at $287K in Q3 2020. 188 funds tracked by Wall St. Rank hold IOSP as of Q1 2022.

  • Caxton Associates (New York) reported no remaining Innospec position as of Q1 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 2,659 Innospec shares in Q1 2022, an estimated $240K.
  • Caxton Associates (New York) first reported a position in Innospec in Q3 2020 and held it in 4 quarters.
  • Caxton Associates (New York)'s Innospec position peaked at $287K in Q3 2020.
  • 188 funds tracked by Wall St. Rank held Innospec as of Q1 2022.

Based on Caxton Associates (New York)'s 13F filing for Q1 2022, filed 16 May 2022.